오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bondi vite pty ltd - biotin,calcium pantothenate,cyanocobalamin,d-alpha-tocopheryl acid succinate,folic acid,heavy magnesium oxide,nicotinamide,pyridoxine hydrochloride,riboflavin,selenomethionine,sodium ascorbate,thiamine hydrochloride,zinc oxide -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bondi vite pty ltd - biotin,calcium pantothenate,cyanocobalamin,d-alpha-tocopheryl acid succinate,ferrous fumarate,folic acid,heavy magnesium oxide,nicotinamide,pyridoxine hydrochloride,riboflavin,sodium ascorbate,thiamine hydrochloride,zinc oxide -

미국 - 영어 - NLM (National Library of Medicine)

a-s medication solutions - chlordiazepoxide hydrochloride (unii: mfm6k1xwdk) (chlordiazepoxide - unii:6rz6xez3cr), clidinium bromide (unii: 91zqw5jf1z) (clidinium - unii:bo76jf850n) - chlordiazepoxide hydrochloride 5 mg - chlordiazepoxide hydrochloride/clidinium bromide is indicated to control the emotional and somatic factors in gastrointestinal disorders. chlordiazepoxide hydrochloride/clidinium bromide may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. chlordiazepoxide hydrochloride/clidinium bromide is contraindicated in the presence of glaucoma (since the anticholinergic component may produce some degree of mydriasis) and in patients with prostatic hypertrophy and benign bladder neck obstruction. it is contraindicated in patients with known hypersensitivity to chlordiazepoxide hydrochloride and/or clidinium bromide. withdrawal symptoms, similar in character to those noted with barbiturates and alcohol (convulsions, tremor, abdominal and muscle cramps, vomiting and sweating), have occurred following abrupt discontinuance of chlordiazepoxide. the more severe withdrawal symptoms have

미국 - 영어 - NLM (National Library of Medicine)

cardinal health - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

미국 - 영어 - NLM (National Library of Medicine)

bryant ranch prepack - chlordiazepoxide hydrochloride (unii: mfm6k1xwdk) (chlordiazepoxide - unii:6rz6xez3cr) - chlordiazepoxide hydrochloride 25 mg - chlordiazepoxide hcl capsules are indicated for the management of anxiety disorders or for the short term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the effectiveness of chlordiazepoxide hcl capsules in long term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. chlordiazepoxide hcl capsules are contraindicated in patients with known hypersensitivity to the drug. chlordiazepoxide is a schedule iv controlled substance. chlordiazepoxide is a benzodiazepine and a cns depressant with a potential for abuse and addiction. abuse is the intentional, non-therapeutic use of a drug, even once, for its desirable psychological or physiological effects. misuse is the intentional use, for therapeutic pur

미국 - 영어 - NLM (National Library of Medicine)

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

미국 - 영어 - NLM (National Library of Medicine)

a-s medication solutions - chlordiazepoxide hydrochloride (unii: mfm6k1xwdk) (chlordiazepoxide - unii:6rz6xez3cr), clidinium bromide (unii: 91zqw5jf1z) (clidinium - unii:bo76jf850n) - chlordiazepoxide hydrochloride 5 mg - based on a review of this drug by the national academy of sciences — national research council and/or other information, fda has classified the indications as follows: "possibly" effective: as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. final classification of the less-than-effective indications requires further investigation. chlordiazepoxide hcl/clidinium bromide is contraindicated in the presence of glaucoma (since the anticholinergic component may produce some degree of mydriasis) and in patients with prostatic hypertrophy and benign bladder neck obstruction. it is contraindicated in patients with known hypersensitivity to chlordiazepoxide hydrochloride and/or clidinium bromide. withdrawal symptoms, similar in character to those noted with barbiturates and alcohol (convulsions, tremor, abdominal and muscle cramps, vomiting and sweating), have occurred following abrupt disc

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

factors group australia pty ltd - heavy magnesium oxide, quantity: 1.9353 mg/g (equivalent: magnesium, qty 1.167 mg/g); magnesium citrate, quantity: 302.184 mg/g (equivalent: magnesium, qty 48.833 mg/g); ascorbic acid, quantity: 8.33 mg/g; pyridoxal 5-phosphate monohydrate, quantity: 1.3054 mg/g (equivalent: pyridoxine, qty 0.833 mg/g); glutamine, quantity: 16.667 mg/g; riboflavin, quantity: 1.667 mg/g - powder - excipient ingredients: xylitol; citric acid; steviol glycosides; hypromellose; flavour - maintain/support body electrolyte balance ; aids/assists teeth development ; helps enhance/promote teeth health ; maintain/support healthy body tissues ; maintain/support body tissue repair/regeneration ; helps enhance/promote bone health ; aids/assists healthy bone development/growth/building ; maintain/support muscle health ; maintain/support muscle function ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient)

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

nature's care manufacture pty limited - calcium ascorbate dihydrate,colecalciferol,heavy magnesium oxide,magnesium phosphate pentahydrate,manganese amino acid chelate,pyridoxine hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - biotin,calcium ascorbate dihydrate,calcium carbonate,calcium pantothenate,colecalciferol,cyanocobalamin,d-alpha-tocopheryl acid succinate,folic acid,heavy magnesium oxide,nicotinamide,potassium sulfate,pyridoxine hydrochloride,quercetin,riboflavine,sodium ascorbate,thiamine nitrate,zinc oxide -